Stock PHIA PHILIPS NV
Add to a list
To use this feature you must be a member
Log inSign up

Financials Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Market Closed - Euronext Amsterdam
Other stock markets
 11:35:26 2024-04-26 am EDT 		5-day change 1st Jan Change
19.74 EUR +2.49% Intraday chart for Philips NV +4.75% -6.36%
Apr. 26 ResMed tops quarterly profit estimates on strong demand for sleep apnea devices RE
Apr. 23 PHILIPS NV : Jefferies reiterates its Sell rating ZD

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 38,967 39,817 28,161 12,398 19,314 17,897 - -
Enterprise Value (EV) 1 42,989 43,525 32,837 18,485 25,131 23,162 22,196 21,485
P/E ratio 33.5 x 33.9 x 8.98 x -7.69 x -41.3 x 27.9 x 17.4 x 15.3 x
Yield 1.95% 1.94% 2.59% 6.07% 4.03% 4.48% 4.66% 5.23%
Capitalization / Revenue 2 x 2.04 x 1.64 x 0.7 x 1.06 x 0.95 x 0.91 x 0.87 x
EV / Revenue 2.21 x 2.23 x 1.91 x 1.04 x 1.38 x 1.23 x 1.12 x 1.04 x
EV / EBITDA 11.9 x 11.7 x 11 x 8.02 x 8.83 x 7.5 x 6.46 x 5.84 x
EV / FCF 40.8 x 23.5 x 36.5 x -19.2 x 15.9 x 20.2 x 15.1 x 15.3 x
FCF Yield 2.45% 4.26% 2.74% -5.2% 6.3% 4.95% 6.62% 6.55%
Price to Book 3.08 x 3.34 x 1.97 x 0.93 x 1.61 x 1.48 x 1.42 x 1.39 x
Nbr of stocks (in thousands) 954,336 950,090 897,866 924,889 915,987 906,403 - -
Reference price 2 40.83 41.91 31.36 13.41 21.08 19.74 19.74 19.74
Announcement Date 1/28/20 1/25/21 1/24/22 1/30/23 1/29/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 19,482 19,535 17,156 17,827 18,169 18,801 19,733 20,609
EBITDA 1 3,615 3,709 2,985 2,305 2,845 3,089 3,438 3,678
EBIT 1 2,563 2,570 2,054 1,318 1,921 2,073 2,366 2,499
Operating Margin 13.16% 13.16% 11.97% 7.39% 10.57% 11.03% 11.99% 12.13%
Earnings before Tax (EBT) 1 1,529 1,490 509 -1,731 -526 869.8 1,451 1,683
Net income 1 1,167 1,187 3,319 -1,608 -466 701.8 1,116 1,253
Net margin 5.99% 6.08% 19.35% -9.02% -2.56% 3.73% 5.66% 6.08%
EPS 2 1.220 1.235 3.494 -1.742 -0.5100 0.7088 1.134 1.291
Free Cash Flow 1 1,053 1,852 900 -961 1,582 1,147 1,470 1,407
FCF margin 5.4% 9.48% 5.25% -5.39% 8.71% 6.1% 7.45% 6.83%
FCF Conversion (EBITDA) 29.13% 49.93% 30.15% - 55.61% 37.14% 42.75% 38.25%
FCF Conversion (Net income) 90.23% 156.02% 27.12% - - 163.47% 131.7% 112.27%
Dividend per Share 2 0.7975 0.8137 0.8137 0.8137 0.8500 0.8852 0.9207 1.032
Announcement Date 1/28/20 1/25/21 1/24/22 1/30/23 1/29/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 8,554 8,057 4,156 4,944 3,918 4,177 8,095 4,310 5,422 4,167 4,470 4,471 5,062 4,193 4,579 4,733 5,431 -
EBITDA - - - - - - - - - - - - 896 - - - - -
EBIT 662 - 512 - 243 216 459 209 651 359 453 457 653 - - - - -
Operating Margin 7.74% - 12.32% - 6.2% 5.17% 5.67% 4.85% 12.01% 8.62% 10.13% 10.22% 12.9% - - - - -
Earnings before Tax (EBT) - - - - - - - - 7 - - 130 - - - - - -
Net income 1 246 - 2,973 157 -151 -22 -173 -1,330 -106 - 72 88 39 -16.5 64.05 161.2 293.7 -
Net margin 2.88% - 71.54% 3.18% -3.85% -0.53% -2.14% -30.86% -1.95% - 1.61% 1.97% 0.77% -0.39% 1.4% 3.41% 5.41% -
EPS 2 - - 3.101 0.1723 -0.1627 -0.0191 - -1.436 -0.1149 - 0.0800 0.0900 0.0400 -0.0182 0.0708 0.1788 0.3187 -
Dividend per Share 2 - - - 0.8137 - - - - 0.8137 - - - - - - - - -
Announcement Date 7/20/20 7/26/21 10/18/21 1/24/22 4/25/22 7/25/22 7/25/22 10/24/22 1/30/23 4/24/23 7/24/23 10/23/23 1/29/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 4,022 3,708 4,676 6,087 5,817 5,265 4,299 3,588
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.113 x 0.9997 x 1.566 x 2.641 x 2.045 x 1.705 x 1.25 x 0.9755 x
Free Cash Flow 1 1,053 1,852 900 -961 1,582 1,147 1,470 1,407
ROE (net income / shareholders' equity) 14.9% 9.7% 25.3% 6.1% 9.08% 10.6% 12.4% 12.5%
ROA (Net income/ Total Assets) 6.94% 6.63% 5.1% 2.74% 3.82% 2.64% 3.99% 3.77%
Assets 1 16,817 17,906 65,043 -58,658 -12,197 26,570 27,998 33,246
Book Value Per Share 2 13.30 12.50 15.90 14.40 13.10 13.30 14.00 14.20
Cash Flow per Share 2 2.090 2.900 1.710 -0.1900 2.330 1.810 2.500 2.610
Capex 1 978 924 729 788 554 953 992 1,028
Capex / Sales 5.02% 4.73% 4.25% 4.42% 3.05% 5.07% 5.03% 4.99%
Announcement Date 1/28/20 1/25/21 1/24/22 1/30/23 1/29/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Philips NV

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
19.74 EUR
Average target price
20.36 EUR
Spread / Average Target
+3.11%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
PHILIPS NV Stock Philips NV
-6.36% 19.11B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
RESMED, INC. Stock ResMed, Inc.
+26.76% 32.03B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. PHIA Stock
  4. Financials Philips NV